PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2546752-4	1989	The effect of iodide to inhibit both TSH- and insulin-like growth factor-I-stimulated growth in FRTL5 cells was abolished by concomitant culture with methimazole, and no iodide inhibition of growth was observed in L6 myoblasts and BRL 30E hepatocytes.	Methimazole	150-161	insulin-like growth factor 1	Rattus norvegicus	46-74	
2327214-6	1990	Methimazole therapy significantly decreased serum T4, IGF-I, epiphyseal growth plate width, and longitudinal growth rate compared to controls.	Methimazole	0-11	insulin-like growth factor 1	Rattus norvegicus	54-59	
16280976-1	2005	PURPOSE: Methimazole (MMI), an anti-thyroid drug known to reduce serum levels of L-thyroxine (T4) and insulin-like growth factor-1 (IGF-1), has been previously reported to increase the incidence of neovascularization (NV) in an oxygen-induced retinopathy (OIR) model of retinopathy of prematurity (ROP) in rats.	Methimazole	9-20	insulin-like growth factor 1	Rattus norvegicus	102-130	
16280976-1	2005	PURPOSE: Methimazole (MMI), an anti-thyroid drug known to reduce serum levels of L-thyroxine (T4) and insulin-like growth factor-1 (IGF-1), has been previously reported to increase the incidence of neovascularization (NV) in an oxygen-induced retinopathy (OIR) model of retinopathy of prematurity (ROP) in rats.	Methimazole	9-20	insulin-like growth factor 1	Rattus norvegicus	132-137	
2539965-0	1989	Direct effect of methimazole on rat thyroidal cell growth induced by thyrotropin and insulin-like growth factor I.	Methimazole	17-28	insulin-like growth factor 1	Rattus norvegicus	85-113